These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23519958)

  • 1. Self-reported quality of life in long-term survivors of childhood lymphoblastic malignancy treated with hematopoietic stem cell transplantation versus conventional therapy.
    Sundberg KK; Wettergren L; Frisk P; Arvidson J
    Pediatr Blood Cancer; 2013 Aug; 60(8):1382-7. PubMed ID: 23519958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A French cohort of childhood leukemia survivors: impact of hematopoietic stem cell transplantation on health status and quality of life.
    Berbis J; Michel G; Chastagner P; Sirvent N; Demeocq F; Plantaz D; Barlogis V; Contet A; Poirée M; Kanold J; Galambrun C; Baumstarck K; Chambost H; Auquier P
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1065-72. PubMed ID: 23618717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age.
    Perkins JL; Kunin-Batson AS; Youngren NM; Ness KK; Ulrich KJ; Hansen MJ; Petryk A; Steinberger J; Anderson FS; Baker KS
    Pediatr Blood Cancer; 2007 Dec; 49(7):958-63. PubMed ID: 17474113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source.
    Ferrá C; Sanz J; de la Cámara R; Sanz G; Bermúdez A; Valcárcel D; Rovira M; Serrano D; Caballero D; Espigado I; Morgades M; Heras I; Solano C; Duarte R; Barrenetxea C; García-Noblejas A; Díez-Martin JL; Iriondo A; Carreras E; Sierra J; Sanz MA; Ribera JM;
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):957-66. PubMed ID: 20144909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autologous versus allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia].
    Wang GR; Xu Y; Zou DH; Zhao YZ; Wang M; Han MZ; Feng SZ; Yan WW; Qiu LG
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):544-8. PubMed ID: 16995310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study.
    Bunin N; Aplenc R; Kamani N; Shaw K; Cnaan A; Simms S
    Bone Marrow Transplant; 2003 Sep; 32(6):543-8. PubMed ID: 12953124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation.
    Frick E; Borasio GD; Zehentner H; Fischer N; Bumeder I
    Psychooncology; 2004 Feb; 13(2):116-24. PubMed ID: 14872530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with poor quality of life in survivors of childhood acute lymphoblastic leukemia and lymphoma.
    Kanellopoulos A; Hamre HM; Dahl AA; Fosså SD; Ruud E
    Pediatr Blood Cancer; 2013 May; 60(5):849-55. PubMed ID: 23335116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia.
    Zohren F; Czibere A; Bruns I; Fenk R; Schroeder T; Gräf T; Haas R; Kobbe G
    Bone Marrow Transplant; 2009 Dec; 44(12):785-92. PubMed ID: 19430496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in adult survivors after paediatric allo-SCT.
    Löf CM; Winiarski J; Giesecke A; Ljungman P; Forinder U
    Bone Marrow Transplant; 2009 Mar; 43(6):461-8. PubMed ID: 18936733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.
    El-Cheikh J; Crocchiolo R; Furst S; Stoppa AM; Ladaique P; Faucher C; Calmels B; Lemarie C; De Colella JM; Granata A; Coso D; Bouabdallah R; Chabannon C; Blaise D
    Am J Hematol; 2013 May; 88(5):370-4. PubMed ID: 23460414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experiences and review of the literature.
    Yoshihara T; Morimoto A; Kuroda H; Imamura T; Ishida H; Tsunamoto K; Naya M; Hibi S; Todo S; Imashuku S
    Bone Marrow Transplant; 2006 Jan; 37(1):25-31. PubMed ID: 16247416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies.
    Braamse AM; Gerrits MM; van Meijel B; Visser O; van Oppen P; Boenink AD; Cuijpers P; Huijgens PC; Beekman AT; Dekker J
    Bone Marrow Transplant; 2012 Jun; 47(6):757-69. PubMed ID: 21725373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
    Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument.
    Wettergren L; Sprangers M; Björkholm M; Langius-Eklöf A
    Psychooncology; 2008 Apr; 17(4):338-46. PubMed ID: 17614094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience.
    Hallböök H; Hägglund H; Stockelberg D; Nilsson PG; Karlsson K; Björkholm M; Linderholm M; Wahlin A; Linder O; Smedmyr B;
    Bone Marrow Transplant; 2005 Jun; 35(12):1141-8. PubMed ID: 15834433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant.
    Corvò R; Zeverino M; Vagge S; Agostinelli S; Barra S; Taccini G; Van Lint MT; Frassoni F; Bacigalupo A
    Radiother Oncol; 2011 Mar; 98(3):382-6. PubMed ID: 21339008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic cell transplantation in acute lymphoblastic leukemia: better long term event-free survival with conditioning regimens containing total body irradiation.
    Granados E; de La Cámara R; Madero L; Díaz MA; Martín-Regueira P; Steegmann JL; Arranz R; Figuera A; Fernández-Rañada JM
    Haematologica; 2000 Oct; 85(10):1060-7. PubMed ID: 11025598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up.
    Shimoni A; Hardan I; Ayuk F; Schilling G; Atanackovic D; Zeller W; Yerushalmi R; Zander AR; Kroger N; Nagler A
    Cancer; 2010 Aug; 116(15):3621-30. PubMed ID: 20564132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.